MNS1 promotes hepatocarcinogenesis and metastasis via activating PI3K/AKT by translocating β-catenin and predicts poor prognosis.
Yong YiMin-Cheng YuPei-Yao FuGao LiuPei-Yun ZhouRuo-Yu GuanCheng ZhouBao-Ye SunShuang-Jian QiuPublished in: Liver international : official journal of the International Association for the Study of the Liver (2021)
MNS1 promotes HCC growth and metastasis via activating PI3K/AKT signalling and may serve as an important prognostic biomarker as well as potential novel therapeutic target for HCC.